Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 040139/0667 | |
| Pages: | 17 |
| | Recorded: | 10/26/2016 | | |
Attorney Dkt #: | A-1668-US-PCT |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
|
Issue Dt:
|
08/21/2018
|
Application #:
|
15101373
|
Filing Dt:
|
06/02/2016
|
Publication #:
|
|
Pub Dt:
|
10/20/2016
| | | | |
Title:
|
CRYSTALLINE FORMS OF N-(4-((3-(2-AMINO-4-PYRIMIDINYL)-2-PYRIDINYL)OXY)PHENYL)-4-(4-METHYL -2-THIENYL)-1-PHTHALAZINAMINE SALTS AND USES THEREOF
|
|
Assignee
|
|
|
ONE AMGEN CENTER DR. |
THOUSAND OAKS, CALIFORNIA 91320 |
|
Correspondence name and address
|
|
AMGEN INC
|
|
ONE AMGEN CENTER DR.
|
|
THOUSAND OAKS, CA 91320
|
Search Results as of:
09/23/2024 07:43 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|